$TirzepatidePriceGuide
Head-to-head comparison

Mochi vs Henry Meds

Two compounded tirzepatide programs head-to-head — Mochi's NP-led membership model vs Henry Meds' async intake — on price, oversight, and pharmacy.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.
 Mochi HealthHenry Meds
From / month$209/mo$297/mo
Medication typeCompoundedCompounded
FDA statusNot FDA-approvedNot FDA-approved
Clinical oversightNP-ledClinician + async intake
Pharmacy / fulfillment503A503A
InsuranceCash-pay (HSA/FSA)Cash-pay (HSA/FSA)

Pricing verified as of July 2026 — confirm current figures with each provider. Compounded medications are not FDA-approved.

Clinical model

Both are compounded tirzepatide programs on the 503A pathway. Mochi is NP-led with a membership style; Henry Meds uses asynchronous intake. Neither dispenses an FDA-approved product.

Pharmacy & fulfillment

Both fulfill via 503A compounding pharmacies. Compounded tirzepatide is not FDA-approved; ask either provider for a certificate of analysis.

Pros & trade-offs

Strengths and trade-offs

Mochi Health

Strengths
  • Lower headline price ($209)
  • NP-led membership support
Trade-offs
  • Not FDA-approved
  • NP-led

Henry Meds

Strengths
  • Large established platform
  • Convenient async intake
Trade-offs
  • Not FDA-approved
  • Higher price than Mochi
  • Async model

Who each may be best for

Mochi may suit those wanting a lower price with NP support; Henry Meds may suit those preferring a large async brand. For flat-rate compounded tirzepatide with named 503A pharmacies, see the NexLife review.

Top pick · flat-rate compounded
$115/mo*
All doses one price · coaching included
See NexLife pricing →
FAQ

Questions

Is Mochi or Henry Meds cheaper?

Mochi (~$209/mo) is generally lower than Henry Meds (~$297/mo). Both are compounded and not FDA-approved; weigh oversight and pharmacy transparency too. See NexLife pricing

Are both Mochi and Henry Meds compounded?

Yes — both dispense compounded tirzepatide via 503A pharmacies, which is not FDA-approved.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.

Keep comparing

Related comparisons & cost guides